Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Sodium fusidate
Leo Laboratories Limited
D06AX; D06AX01
Sodium fusidate
20 milligram(s)/gram
Ointment
Product subject to prescription which may not be renewed (A)
Other antibiotics for topical use; fusidic acid
Marketed
1977-04-01
PACKAGE LEAFLET: INFORMATION FOR THE USER FUCIDIN ® 20 MG/G OINTMENT sodium fusidate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT FUCIDIN ® OINTMENT IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU USE FUCIDIN ® OINTMENT 3. HOW TO USE FUCIDIN ® OINTMENT 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE FUCIDIN ® OINTMENT 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT FUCIDIN ® OINTMENT IS AND WHAT IT IS USED FOR Fucidin ointment belongs to a group of medicines called antibiotics. The antibiotic in this product is called sodium fusidate. Fucidin ointment works by killing germs (bacteria) that cause infections. It is used to treat skin infections such as those caused by bacteria called _Staphylococcus aureus. _ 2. WHAT YOU NEED TO KNOW BEFORE YOU USE FUCIDIN ® OINTMENT DO NOT USE FUCIDIN OINTMENT: • If you are allergic to sodium fusidate or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR, PHARMACIST OR NURSE BEFORE USING FUCIDIN OINTMENT • Do not use Fucidin ointment for a long time as the germs (bacteria) may no longer be killed by the antibiotic. • Avoid getting the ointment in your eyes (e.g. accidentally from your hands or by using it too close to your eyes) as it could irritate (sting) them. OTHER MEDICINES AND FUCIDIN OINTMENT Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. PREGNANCY AND BREAST-FEEDING If you are pregnant Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fucidin 20 mg/g ointment 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of ointment contains 20 mg sodium fusidate. Excipients with known effect: Contains cetyl alcohol 4 mg/g, wool fat (lanolin) 46 mg/g and butylhydroxytoluene (E321). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Ointment Translucent, yellowish to white ointment. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Fucidin 20 mg/g ointment is indicated in the topical treatment of infections due to micro - organisms sensitive to this anti-infective such as_ Staphylococcus aureus_. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and Paediatric Population_ Apply three to four times daily as required. Less frequent application may be adequate for covered lesions. Method of administration Cutaneous use. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Bacterial resistance among Staphylococcus aureus has been reported to occur with the use of topical Fucidin. As with all antibiotics, extended or recurrent use of fusidic acid may increase the risk of developing antibiotic resistance. Fucidin ointment contains cetyl alcohol and wool fat (lanolin). These excipients may cause local skin reactions (e.g. contact dermatitis). Fucidin ointment contains butylhydroxytoluene (E321) which may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous membranes. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ Read the complete document